Cargando…

Comparison of Tumor Microenvironments Between Primary Tumors and Brain Metastases in Patients With NSCLC

INTRODUCTION: This study investigates the immune profile of the primary lung tumors and the corresponding brain metastasis from patients with NSCLC using multiplex fluorescence immunohistochemistry. METHODS: The study evaluated 34 patients who underwent autopsy or surgical resection for brain metast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikarashi, Daiki, Okimoto, Tamio, Shukuya, Takehito, Onagi, Hiroko, Hayashi, Takuo, Sinicropi-Yao, Sara L., Amann, Joseph M., Nakatsura, Tetsuya, Kitano, Shigehisa, Carbone, David P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501504/ https://www.ncbi.nlm.nih.gov/pubmed/34647108 http://dx.doi.org/10.1016/j.jtocrr.2021.100230

Ejemplares similares

High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs
por: Onagi, Hiroko, et al.
Publicado: (2022)

Plasma cell infiltration and treatment effect in breast cancer patients treated with neoadjuvant chemotherapy
por: Sakaguchi, Asumi, et al.
Publicado: (2021)

Complete Pathological Response to Neoadjuvant Pembrolizumab in a Patient With Chemoresistant Upper Urinary Tract Urothelial Carcinoma: A Case Report
por: Ikarashi, Daiki, et al.
Publicado: (2020)

Tumor microenvironment in NSCLC suppresses NK cells function
por: Cremer, Isabelle, et al.
Publicado: (2012)

Malignant pleural mesothelioma showing rare morphology indistinguishable from myxofibrosarcoma concomitant with EGFR-mutated lung adenocarcinoma: A case report
por: Onagi, Hiroko, et al.
Publicado: (2021)

Impact of the immune molecular profile of the tumor microenvironment on the prognosis of NSCLC
por: Ying, Hangjie, et al.
Publicado: (2023)

Tumor microenvironment differences between primary tumor and brain metastases
por: Cacho-Díaz, Bernardo, et al.
Publicado: (2020)

Successful restart of chemotherapy in a patient with primary mediastinal nonseminomatous germ cell tumor after COVID‐19 infection
por: Tanabe, Yuki, et al.
Publicado: (2022)

BSCI-09. Multiomic single cell analysis reveals emerging principles of tumor immune microenvironment inherent to NSCLC brain metastases
por: Wen, Lei, et al.
Publicado: (2021)

The microenvironment of brain metastases from solid tumors
por: Srinivasan, Ethan S, et al.
Publicado: (2021)

Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma
por: Hatogai, Ken, et al.
Publicado: (2016)

Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases
por: Trembath, Dimitri G., et al.
Publicado: (2021)

An immunogold single extracellular vesicular RNA and protein ((Au)SERP) biochip to predict responses to immunotherapy in non‐small cell lung cancer patients
por: Nguyen, Luong T. H., et al.
Publicado: (2022)

Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model
por: Fujinami, Norihiro, et al.
Publicado: (2016)

Peptide intra-tumor injection for cancer immunotherapy: Enhancement of tumor cell antigenicity is a novel and attractive strategy
por: Nobuoka, Daisuke, et al.
Publicado: (2013)

Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti–PD-1 response in NSCLC
por: Bullock, Bonnie L, et al.
Publicado: (2019)

Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases
por: Yap, May Lin, et al.
Publicado: (2019)

Th1(high) in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC
por: Jian, Huang, et al.
Publicado: (2017)

Biology of NSCLC: Interplay between Cancer Cells, Radiation and Tumor Immune Microenvironment
por: Tubin, Slavisa, et al.
Publicado: (2021)

IgG4-related mastitis characterized by skin thickening of the breast: a case report
por: Itakura, Moe, et al.
Publicado: (2023)

Transformation from adenocarcinoma to squamous cell lung carcinoma with MET amplification after lorlatinib resistance: A case report
por: Ueda, Shoko, et al.
Publicado: (2021)

Development of a Multicellular 3D Tumor Model to Study Cellular Heterogeneity and Plasticity in NSCLC Tumor Microenvironment
por: Arora, Leena, et al.
Publicado: (2022)

Correction: Th1(high) in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC
por: Jian, Huang, et al.
Publicado: (2017)

Clinicopathological and mutational differences between tumors with multiple metastases and single lung metastasis in colorectal cancer
por: Yanai, Yuka, et al.
Publicado: (2020)

Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR
por: Ueno, Takayuki, et al.
Publicado: (2022)

Acute myocarditis during adjuvant therapies for breast cancer: a case report
por: Ushiyama, Yumiko, et al.
Publicado: (2023)

Immunological profiles of the breast cancer microenvironment represented by tumor-infiltrating lymphocytes and PD-L1 expression
por: Hanamura, Toru, et al.
Publicado: (2022)

Characterization of the immune microenvironment in brain metastases from different solid tumors
por: Jiang, Jinling, et al.
Publicado: (2020)

Evolution of tumor microenvironment in colorectal liver metastases under treatment stress
por: Huang, Na, et al.
Publicado: (2022)

Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade
por: Wang, Shuhang, et al.
Publicado: (2022)

The Impact of NOTCH Pathway Alteration on Tumor Microenvironment and Clinical Survival of Immune Checkpoint Inhibitors in NSCLC
por: Li, Xiaohua, et al.
Publicado: (2021)

Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects
por: Peters, Solange, et al.
Publicado: (2022)

Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination
por: van der Woude, Lieke L, et al.
Publicado: (2022)

Novel hypoxia-related gene signature for predicting prognoses that correlate with the tumor immune microenvironment in NSCLC
por: Li, Zhaojin, et al.
Publicado: (2023)

Heterogeneous Outcomes of Immune Checkpoint Inhibitor Rechallenge in Patients With NSCLC: A Systematic Review and Meta-Analysis
por: Xu, Shiting, et al.
Publicado: (2022)

Telomerase deficiency and dysfunctional telomeres in the lung tumor microenvironment impair tumor progression in NSCLC mouse models and patient-derived xenografts
por: Piñeiro-Hermida, Sergio, et al.
Publicado: (2023)

Combination therapy using molecular‐targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma
por: Kitano, Hiroyuki, et al.
Publicado: (2017)

Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases
por: Qin, Jian Zhong, et al.
Publicado: (2013)

Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases
por: Roato, Ilaria, et al.
Publicado: (2018)

Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases
por: Chute, Colleen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rd11jbul1g2ksnleddugfjqbtu